The Anglo-Swedish pharmaceutical company AstraZeneca has changed the name of its COVID-19 vaccine.
You
might also like: Shortages of COVID-19 vaccine supplies are being felt
globally, not excluding the EU and the UK. Do companies fulfil their
obligations and where will new manufacturing facilities be created?Learn
more
The vaccine previously known as COVID-19
Vaccine AstraZeneca is now called Vaxzevria according
to the European Medicine Agency's (EMA) website. The Sweden National Food Agency has
noted that only the name of the medicine has changed, with no other alterations.
However, the information about the vaccine, its labels and package may look different
in the future.
There has been no official statement on the reasons behind the name change.
Previously, the administration of the AstraZeneca vaccine has been suspended in a number of countries in the EU and across the world. As of 25 March, the
majority of them have resumed
the use of the vaccine after EMA concluded on 18 March that “benefits still outweigh the risks”
even if acknowledging the “possible
link to rare blood clots with low blood platelets”.
A U.S. study published
on 25 March and involving over 32,000 volunteers showed that the vaccine both
safe and highly effective. It demonstrated79% efficiency at
stopping symptomatic COVID-19 and 100% efficiency at preventing serious cases.
No safety issues regarding blood clots were reported.
Image
credit: Sundry
Photography via iStock